| INK Ultra Money Free |
Latest 10 SEC filings (by transaction date) for CVS within the last 6 months | [?] |
![]() ![]() |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Aug 5/22 | Aug 4/22 | Lotvin Alan | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -22,541 | $104.00 |
Aug 5/22 | Aug 4/22 | Lotvin Alan | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 22,541 | $62.21 |
Aug 5/22 | Aug 4/22 | Lotvin Alan | Direct Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 ![]() | -22,541 | |
Aug 5/22 | Aug 3/22 | Lotvin Alan | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -50,501 | $98.00 |
Aug 5/22 | Aug 3/22 | Lotvin Alan | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 50,501 | $54.19 |
Aug 5/22 | Aug 3/22 | Lotvin Alan | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -70,398 | $98.00 |
Aug 5/22 | Aug 3/22 | Lotvin Alan | Direct Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 ![]() | -50,501 | |
Aug 5/22 | Aug 3/22 | Lotvin Alan | Direct Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 ![]() | -70,398 | |
Aug 5/22 | Aug 3/22 | Lotvin Alan | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 70,398 | $58.34 |
Aug 5/22 | Aug 3/22 | Finke Daniel P | Direct Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 ![]() | -9,546 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for CVS within the last 6 months | [?] |
![]() ![]() |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Aug 5/22 | Aug 4/22 | Lotvin Alan | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -22,541 | $104.00 |
Aug 5/22 | Aug 4/22 | Lotvin Alan | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 22,541 | $62.21 |
Aug 5/22 | Aug 3/22 | Lotvin Alan | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -50,501 | $98.00 |
Aug 5/22 | Aug 3/22 | Lotvin Alan | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 50,501 | $54.19 |
Aug 5/22 | Aug 3/22 | Lotvin Alan | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -70,398 | $98.00 |
Aug 5/22 | Aug 4/22 | Lotvin Alan | Direct Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 ![]() | -22,541 | |
Aug 5/22 | Aug 3/22 | Lotvin Alan | Direct Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 ![]() | -50,501 | |
Aug 5/22 | Aug 3/22 | Lotvin Alan | Direct Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 ![]() | -70,398 | |
Aug 5/22 | Aug 3/22 | Lotvin Alan | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 70,398 | $58.34 |
Aug 5/22 | Aug 3/22 | Finke Daniel P | Direct Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 ![]() | -9,546 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Quest Diagnostics (N:DGX) |
Privia Health Group (OQ:PRVA) |
Chemed (N:CHE) |